Analysis of immunological markers associated with the clinical response to INFb therapy in multiple sclerosis

被引：0
|
作者：
Zayat, M [1 ]
Comabella, M [1 ]
Río, J [1 ]
Espejo, C [1 ]
Castillo, M [1 ]
Montalban, X [1 ]
机构：
[1] Hosp Gen Valle Hebron, Barcelona, Spain
来源：
MULTIPLE SCLEROSIS | 2004年 / 10卷 / 7032期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [31] Use of superficial markers for estimation of the intensity of immunological process in multiple sclerosis
    Poryadin, GV
    Makarkov, AI
    Boiko, AN
    Salmasi, ZM
    Demina, TL
    Gusev, EI
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1997, 124 (09) : 924 - 926
  • [32] Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers
    Grossman, Iris
    Avidan, Nili
    Singer, Clara
    Goldstaub, Dan
    Hayardeny, Liat
    Eyal, Eli
    Ben-Asher, Edna
    Paperna, Tamar
    Pe'er, Itsik
    Lancet, Doron
    Beckmann, Jacques S.
    Miller, Ariel
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (08): : 657 - 666
  • [33] Association between peripheral blood immunological status and intrathecal inflammatory markers differentiate multiple sclerosis clinical phenotypes
    Turcic, Ana
    Knezevic, Josip
    Zaninovic, Ljiljana
    Habek, Mario
    Skoric, Magdalena Krbot
    Babic, Antonija
    Vogrinc, Zeljka
    ACTA NEUROLOGICA BELGICA, 2024, : 1935 - 1944
  • [34] RECENT ADVANCES IN IMMUNOLOGICAL BASIS AND THERAPY OF MULTIPLE-SCLEROSIS
    TOURBAH, A
    FONTAINE, B
    LYONCAEN, O
    REVUE NEUROLOGIQUE, 1993, 149 (6-7) : 373 - 384
  • [35] MULTIPLE-SCLEROSIS - IMMUNOLOGICAL FINDINGS AND POSSIBLE IMPLICATIONS FOR THERAPY
    HINTZEN, RQ
    POLMAN, CH
    LUCAS, CJ
    VANLIER, RAW
    JOURNAL OF NEUROIMMUNOLOGY, 1992, 39 (1-2) : 1 - 10
  • [36] Predictive markers to IFN β therapy in Multiple Sclerosis patients
    Charbit, H.
    Karussis, D.
    Petrou, P.
    Vaknin-Dembinsky, A.
    Lavon, I
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S28 - S28
  • [37] CSF Immunological Biomarkers Associated with Axonal Damage in Multiple Sclerosis
    Villar, Luisa
    Picon, Carmen
    Alenda, Raquel
    Garcia-Caldentey, Juan
    Costa-Frossard, Lucienne
    Espino, Mercedes
    Alvarez-Cermeno, Jose
    NEUROLOGY, 2013, 80
  • [38] Fatigue is not associated with raised inflammatory markers in multiple sclerosis
    Giovannoni, G
    Thompson, AJ
    Miller, DH
    Thompson, EJ
    NEUROLOGY, 2001, 57 (04) : 676 - 681
  • [39] Lipoprotein markers associated with disability from multiple sclerosis
    Gafson, A. R.
    Thorne, T.
    McKechnie, C. I. J.
    Jimenez, B.
    Nicholas, R.
    Matthews, P. M.
    SCIENTIFIC REPORTS, 2018, 8
  • [40] Fatigue is not associated with raised inflammatory markers in multiple sclerosis
    Iriarte, J
    NEUROLOGY, 2002, 58 (07) : 1134 - 1134
12345